GLPwatch
Danuglutide
Pipeline · GLP-1 receptor agonist
Last updated 2026-05-28Danuglutide is a GLP-1 receptor agonist, meaning it mimics a natural gut hormone to help regulate digestion and blood sugar. It is currently in development and not yet approved for any branded products or specific treatments.
AI summary of the sources below.
| Mechanism | GLP-1 receptor agonist Mimics GLP-1, a gut hormone that raises insulin, lowers blood sugar, and reduces appetite. |
|---|---|
| Status | Pipeline |
| Branded products | — (none approved) |
| Manufacturer(s) | — |
How Danuglutide connects
Trials (0)
No trials linked to this molecule in the current sample.
Top research (0)
No papers linked to this molecule in the current sample.